González-Espinoza, Liliana <br/><br/>
Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial.  [electronic resource] 

 -  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  May 2012 
 - 2023-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2385 
<br/><br/><label>Standard No.: </label>10.1093/ndt/gfr579  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Inflammatory Agents--therapeutic use<br/>Biomarkers--blood<br/>C-Reactive Protein--metabolism<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Inflammation--prevention & control<br/>Interleukin-6--blood<br/>Kidney Failure, Chronic--blood<br/>Male<br/>Middle Aged<br/>Pentoxifylline--therapeutic use<br/>Renal Dialysis<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--blood